Cancer Vaccine Institute News

Dr. Denise Cecil, CVI Principal Scientist, was awarded an honorable mention for her abstract and presentation of her work on the link...

Gizmodo, the science, technology, and design website, selected the Cancer Vaccine Institute as a winner of the 2023 Gizmodo Science Fair for the development of our HER2 ICD DNA breast cancer vaccine. Read full article on Gizmodo: https://gizmodo.com/breast-cancer-vaccine-university-washington-her2-1850100926 Here is information about the Gizmodo Science Fair from their website: “Welcome to the 2023 Gizmodo Science Fair, where we’re celebrating the projects that inspired us, s

Seattle Met Magazine recently interviewed CVI Director, Dr. Nora Disis, and CVI Director of Clinical Trials, Dr. Shaveta Vinayak on our...

We're excited to see the findings from our recent publication in JAMA Oncology describing our Phase I clinical trial with the HER2 ICD...

Dr. Nora Disis, CVI Director, and Dr. Nicole Kretzer, Clinical Acting Instructor, spoke this past Friday, October 14th as part of...